What is ILEVRO used for?

1 INDICATIONS AND USAGE ILEVRO ® 0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery. ILEVRO ® 0.3% is a nonsteroidal, anti-inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery ( 1 ).

What pharmaceutical form is ILEVRO available in?

ILEVRO: Krople do oczu, zawiesina 3 mg/ml (do oka)

Is ILEVRO OTC or prescription only?

ILEVRO requires a doctor's prescription.

What are the side effects of ILEVRO?

6 ADVERSE REACTIONS Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to the rates in the clinical studies of another drug and may not reflect the rates observed in practice. Most common adverse reactions (5% to 10%) are capsular opacity, decreased visual acuity, foreign body sensation, increased intraocular pressure, and sticky sensation. ( 6.1 ) To report SUSPEC

Who should NOT take ILEVRO?

4 CONTRAINDICATIONS ILEVRO ® 0.3% is contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formula or to other nonsteroidal anti-inflammatory drugs (NSAIDs). Hypersensitivity to any of the ingredients in the formula or to other non-steroidal anti-inflammatory drugs (NSAIDS). ( 4 )

Does ILEVRO interact with other medications?

In vitro studies have demonstrated a very low potential for interaction with other medicinal products and protein binding interactions (see section 5.2). Prostaglandin analogues There are very limited data on the concomitant use of prostaglandin analogues and NEVANAC. Considering their mechanism of action, the concomitant use of these medicinal products is not recommended. Concomitant use of topical NSAIDs and topical steroids may increase the potential for healing problems. Co

Can ILEVRO be used during pregnancy?

8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy Teratogenic Effects. Pregnancy Category C: Reproduction studies performed with nepafenac in rabbits and rats at oral doses up to 10 mg/kg/day have revealed no evidence of teratogenicity due to nepafenac, despite the induction of maternal toxicity. At this dose, the animal plasma exposure to nepafenac and amfenac was approximately 70 and 630 times human plasma exposure at the recommended human topical ophthalmic dose for rats and 20 an

What precautions should be taken with ILEVRO?

No special requirements for disposal.

Who manufactures ILEVRO?

Novartis Europharm Limited (Niemcy)

What ATC class does ILEVRO belong to?

ILEVRO: ATC S01BC10. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

ILEVRO

3 mg/ml, Krople do oczu, zawiesina

INN: Nepafenacum

Data updated: 2026-04-13

Available in:

🇨🇿🇩🇪🇬🇧🇵🇱🇵🇹🇸🇰🇹🇷

Form

Krople do oczu, zawiesina

Dosage

3 mg/ml

Route

do oka

Storage

—

About This Product

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.